Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
United Parcel Service
UPS
|
+$428M |
| 2 |
DexCom
DXCM
|
+$384M |
| 3 |
WIX.com
WIX
|
+$359M |
| 4 |
FTCH
Farfetch Limited Class A Ordinary Shares
FTCH
|
+$254M |
| 5 |
Caesars Entertainment
CZR
|
+$246M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.14B |
| 2 |
Microchip Technology
MCHP
|
+$535M |
| 3 |
Merck
MRK
|
+$512M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$444M |
| 5 |
Illumina
ILMN
|
+$413M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.59% |
| 2 | Healthcare | 18.35% |
| 3 | Consumer Discretionary | 11.3% |
| 4 | Financials | 10.45% |
| 5 | Communication Services | 9.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
VICI Properties
VICI
$29.4B
| $365M | 0.16% |
11,751,739
-4,790,949
| -29% | -$149M |
|
152
Frontdoor
FTDR
$5.02B
| $364M | 0.16% |
7,311,538
+1,058,569
| +17% | +$55.8M |
|
153
Gilead Sciences
GILD
$161B
| $361M | 0.15% |
5,236,547
+775,016
| +17% | +$51.8M |
|
154
Cimpress
CMPR
$2.37B
| $360M | 0.15% |
3,323,962
-22,072
| -0.7% | -$2.23M |
|
155
Intuitive Surgical
ISRG
$121B
| $360M | 0.15% |
1,173,624
-178,599
| -13% | -$50.1M |
|
156
NXP Semiconductors
NXPI
$68B
| $358M | 0.15% |
1,740,767
-91,437
| -5% | -$18.3M |
|
157
Revvity
RVTY
$12.3B
| $358M | 0.15% |
2,315,670
-197,995
| -8% | -$27.8M |
|
158
Cboe Global Markets
CBOE
$29.8B
| $357M | 0.15% |
2,997,749
-274,098
| -8% | -$30.1M |
|
159
Trane Technologies
TT
$106B
| $354M | 0.15% |
1,924,307
+400,946
| +26% | +$71.4M |
|
160
Shopify
SHOP
$148B
| $351M | 0.15% |
2,400,470
+277,890
| +13% | +$34.2M |
|
161
Amgen
AMGN
$203B
| $351M | 0.15% |
1,438,135
+464,461
| +48% | +$114M |
|
162
RingCentral
RNG
$4.05B
| $350M | 0.15% |
1,203,491
-131,659
| -10% | -$37.6M |
|
163
Sysco
SYY
$39.7B
| $347M | 0.15% |
4,459,701
+55,492
| +1% | +$4.48M |
|
164
S&P Global
SPGI
$126B
| $346M | 0.15% |
842,125
+2,682
| +0.3% | +$1.03M |
|
165
T. Rowe Price
TROW
$25B
| $341M | 0.15% |
1,724,778
+22,999
| +1% | +$4.3M |
|
166
Hershey
HSY
$35.4B
| $338M | 0.14% |
1,942,286
-7,510
| -0.4% | -$1.26M |
|
167
Johnson & Johnson
JNJ
$635B
| $337M | 0.14% |
2,043,534
-130,503
| -6% | -$21.6M |
|
168
Howmet Aerospace
HWM
$116B
| $336M | 0.14% |
9,749,017
+4,013,178
| +70% | +$134M |
|
169
Sensient Technologies
SXT
$5.4B
| $334M | 0.14% |
3,857,113
-118,932
| -3% | -$10.1M |
|
170
Oracle
ORCL
$331B
| $332M | 0.14% |
4,269,312
+108,561
| +3% | +$8.5M |
|
171
Rockwell Automation
ROK
$51.4B
| $331M | 0.14% |
1,156,752
+57,826
| +5% | +$15.6M |
|
172
BioMarin Pharmaceuticals
BMRN
$11.5B
| $330M | 0.14% |
3,954,190
-1,039,465
| -21% | -$82.4M |
|
|
GRMN
173
Garmin
GRMN
$46.9B
| $327M | 0.14% |
2,264,189
+261,495
| +13% | +$36.7M |
|
174
Gildan
GIL
$9.25B
| $327M | 0.14% |
8,861,977
+358
| +0% | +$12.5K |
|
175
Best Buy
BBY
$18B
| $326M | 0.14% |
2,836,339
+638,213
| +29% | +$74.5M |
|
Similar funds
Janus Henderson Group's Q2 2021 Portfolio in Review
As of Q2 2021, Janus Henderson Group held 1,725 positions worth $234B, up 6.7% from $219B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Janus Henderson Group's Q2 2021 filing shows 172 new, 741 increased, 667 reduced and 123 closed positions. Its largest new stake was Centessa Pharmaceuticals: 5,680,933 shares worth $120M. The largest sale was Apple, an estimated $1.14B.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 31% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Janus Henderson Group's largest Q2 2021 buy was Centessa Pharmaceuticals: 5,680,933 shares worth $120M.
- Janus Henderson Group added most to United Parcel Service in Q2 2021, an estimated $428M increase.
- Janus Henderson Group's biggest Q2 2021 reduction was Apple, cutting an estimated $1.14B.
- Janus Henderson Group fully exited PRA Health Sciences, Inc. in Q2 2021, selling an estimated $368M.
- Janus Henderson Group's ten largest holdings make up 23% of its $234B portfolio in Q2 2021.
- Janus Henderson Group opened 172 new positions and closed 123 in Q2 2021.
- Janus Henderson Group's portfolio value rose 6.7% quarter-over-quarter to $234B.
Based on Janus Henderson Group's 13F filing for Q2 2021, filed 16 Aug 2021.